120 related articles for article (PubMed ID: 27174917)
1. Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.
Grillo E; Ravelli C; Corsini M; Ballmer-Hofer K; Zammataro L; Oreste P; Zoppetti G; Tobia C; Ronca R; Presta M; Mitola S
Oncotarget; 2016 Jun; 7(23):35353-68. PubMed ID: 27174917
[TBL] [Abstract][Full Text] [Related]
2. Gremlin: a complex molecule regulating wound healing and fibrosis.
O'Reilly S
Cell Mol Life Sci; 2021 Dec; 78(24):7917-7923. PubMed ID: 34731251
[TBL] [Abstract][Full Text] [Related]
3. Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer.
Davies GCG; Dedi N; Jones PS; Kevorkian L; McMillan D; Ottone C; Schulze MED; Scott-Tucker A; Tewari R; West S; Wright M; Rowley TF
MAbs; 2023; 15(1):2289681. PubMed ID: 38084840
[TBL] [Abstract][Full Text] [Related]
4. Increasing thermal stability and improving biodistribution of VEGFR2-binding affibody molecules by a combination of in silico and directed evolution approaches.
Güler R; Svedmark SF; Abouzayed A; Orlova A; Löfblom J
Sci Rep; 2020 Oct; 10(1):18148. PubMed ID: 33097752
[TBL] [Abstract][Full Text] [Related]
5. Current status and prospects of GREM1 research in cancer (Review).
Zhu D; Zhao D; Wang N; Cai F; Jiang M; Zheng Z
Mol Clin Oncol; 2023 Sep; 19(3):69. PubMed ID: 37614374
[TBL] [Abstract][Full Text] [Related]
6. BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction.
Sanders LN; Schoenhard JA; Saleh MA; Mukherjee A; Ryzhov S; McMaster WG; Nolan K; Gumina RJ; Thompson TB; Magnuson MA; Harrison DG; Hatzopoulos AK
Circ Res; 2016 Jul; 119(3):434-49. PubMed ID: 27283840
[TBL] [Abstract][Full Text] [Related]
7. Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma.
Yin M; Tissari M; Tamminen J; Ylivinkka I; Rönty M; von Nandelstadh P; Lehti K; Hyytiäinen M; Myllärniemi M; Koli K
Oncotarget; 2017 Nov; 8(58):98280-98297. PubMed ID: 29228689
[TBL] [Abstract][Full Text] [Related]
8. Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.
Barnes JW; Kucera ET; Tian L; Mellor NE; Dvorina N; Baldwin WW; Aldred MA; Farver CF; Comhair SA; Aytekin M; Dweik RA
Am J Respir Cell Mol Biol; 2016 Oct; 55(4):564-575. PubMed ID: 27187737
[TBL] [Abstract][Full Text] [Related]
9. Gremlin-1 activates Akt/STAT3 signaling, which increases the glycolysis rate in breast cancer cells.
Kim NH; Sung NJ; Youn HS; Park SA
Biochem Biophys Res Commun; 2020 Dec; 533(4):1378-1384. PubMed ID: 33097188
[TBL] [Abstract][Full Text] [Related]
10. Gremlin inhibits UV-induced skin cell damages via activating VEGFR2-Nrf2 signaling.
Ji C; Huang JW; Xu QY; Zhang J; Lin MT; Tu Y; He L; Bi ZG; Cheng B
Oncotarget; 2016 Dec; 7(51):84748-84757. PubMed ID: 27713170
[TBL] [Abstract][Full Text] [Related]
11. Gremlin-1 is a key regulator of endothelial-to-mesenchymal transition in human pulmonary artery endothelial cells.
Zhang Y; Zhang M; Xie W; Wan J; Tao X; Liu M; Zhen Y; Lin F; Wu B; Zhai Z; Wang C
Exp Cell Res; 2020 May; 390(1):111941. PubMed ID: 32145252
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral Gene Transfer of Gremlin Modulates Vascular Endothelial Growth Factor-A-Induced Angiogenesis in Porcine Myocardium.
Pajula JJ; Halonen PJ; Hätinen OP; Ylä-Herttuala S; Nurro J
Hum Gene Ther; 2020 Feb; 31(3-4):211-218. PubMed ID: 31884825
[TBL] [Abstract][Full Text] [Related]
13. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
Liu Y; Li Y; Hou R; Shu Z
J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
[TBL] [Abstract][Full Text] [Related]
14. BMP4 and GREM1 are targets of SHH signaling and downstream regulators of collagen in the penis.
Deng J; Searl T; Ohlander S; Dynda D; Harrington DA; McVary KT; Podlasek CA
J Sex Med; 2024 Apr; 21(5):367-378. PubMed ID: 38451311
[TBL] [Abstract][Full Text] [Related]
15. GREM1 signaling in cancer: tumor promotor and suppressor?
Gao Z; Houthuijzen JM; Ten Dijke P; Brazil DP
J Cell Commun Signal; 2023 Dec; 17(4):1517-1526. PubMed ID: 37615860
[TBL] [Abstract][Full Text] [Related]
16. Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction.
Del Cuore A; Pipitone RM; Casuccio A; Mazzola MM; Puleo MG; Pacinella G; Riolo R; Maida C; Di Chiara T; Di Raimondo D; Zito R; Lupo G; Agnello L; Di Maria G; Ciaccio M; Grimaudo S; Tuttolomondo A
Cardiovasc Diabetol; 2023 Jun; 22(1):148. PubMed ID: 37365645
[TBL] [Abstract][Full Text] [Related]
17. Modeling Receptor Motility along Advecting Lipid Membranes.
Arricca M; Salvadori A; Bonanno C; Serpelloni M
Membranes (Basel); 2022 Jun; 12(7):. PubMed ID: 35877855
[TBL] [Abstract][Full Text] [Related]
18. Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression.
Elemam NM; Malek AI; Mahmoud EE; El-Huneidi W; Talaat IM
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203511
[TBL] [Abstract][Full Text] [Related]
19. Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1.
Mitola S; Ravelli C; Corsini M; Gianoncelli A; Galvagni F; Ballmer-Hofer K; Presta M; Grillo E
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163075
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
